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MicroRNAs (miRNAs) have important roles in regulating a plethora of physiological and pathophysiogical processes including
neurodegeneration. In both human immunodeﬁciency virus (HIV)-associated dementia in humans and its monkey model simian
immunodeﬁciency virus encephalitis (SIVE), we ﬁnd miR-21, a miRNA largely known for its link to oncogenesis, to be
signiﬁcantly upregulated in the brain. In situ hybridization of the diseased brain sections revealed induction of miR-21 in
neurons. miR-21 can be induced in neurons by prolonged N-methyl-D-aspartic acid receptor stimulation, an excitotoxic process
active in HIV and other neurodegenerative diseases. Introduction of miR-21 into human neurons leads to pathological functional
defects. Furthermore, we show that miR-21 speciﬁcally targets the mRNA of myocyte enhancer factor 2C (MEF2C), a
transcription factor crucial for neuronal function, and reduces its expression. MEF2C is dramatically downregulated in neurons
of HIV-associated dementia patients, as well as monkeys with SIVE. Together, this study elucidates a novel role for miR-21 in the
brain,notonlyasapotentialsignatureofneurologicaldisease,butalsoasacrucialeffectorofHIV-inducedneuronaldysfunction
and neurodegeneration.
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Many facets of transcriptional and translation regulation
contribute to the proper functioning of the nervous
system. MicroRNAs (miRNAs) are small RNA molecules that
serve as check points in transcription and translation
processes. They largely function by binding to the 30-UTR
regions of the nascent mRNA molecules resulting in
mRNA destruction or translational inhibition, thus repressing
gene expression.
1 miRNAs regulate a plethora of processes
in the central nervous system (CNS) and have been well
documented in neuronal development, neuronal plasticity
andneuronal differentiation. Recognizingthe role of miRNA in
neuronal development and control of neuronal functional
elements, it is not surprising that many researchers
have sought to link miRNAs to neurodegenerative
diseases. Consequently, impaired miRNA regulation has
been linked to several neurological diseases including
Parkinson’s disease (PD), Alzheimer’s disease (AD),
Huntington’s disease (HD) and other neurodegenerative
disorders.
2,3 Although AD, HD and PD are sporadic and/or
genetic in nature, neurodegeneration also occurs from
infectious etiologies, such as in human immunodeﬁciency
virus (HIV) infection and transmissible spongiform encepha-
lopathies (prion diseases).
HIV-associated neurocognitive disorders (HAND), varying
in severity from an asymptomatic to a mild neurocognitive
impairment and in its most serious form a debilitating
dementia (HIV-associated dementia, HAD), develops in a
subset of individuals infected with HIV-1.
4 HAND results from
an indirect neurotoxicity, as HIV infects macrophages and
microglia, but not neurons, in the brain.
5,6 We previously
identiﬁed dysregulated expression of mRNAs in the brains
of monkeys with simian immunodeﬁciency virus (SIV)
encephalitis(SIVE)andhumanswithHIVencephalitis(HIVE),
revealing altered expression of numerous genes including
those expressed in neurons.
7,8 Here, we describe the
differential regulation of a crucial miRNA, miRNA-21, in the
brains of individuals with SIVE/HIVE and its increased
expression in neurons both in the brains of diseased subjects
and in vitro upon N-methyl-D-aspartic acid (NMDA) receptor
stimulation. When miR-21 is expressed in human neurons,
electrophysiological abnormalities result, linking its expres-
sion to neuronal dysfunction. Given the ability of miRNAs to
modulate cellular mRNAs and proteins and thus cellular
physiology, we identiﬁed a critical neuronal transcription
factor, myocyte enhancer factor 2C (MEF2C), as a target of
miR-21. In line with these results, we observe that MEF2C is
downregulated at the protein level in the hippocampus and
frontal cortex of SIVE/HIVE brains. These ﬁndings further
underscore the importance of epigenetic changes caused by
miRNA in context of neurological disease and highlights the
regulatory loop, in which miRNAs function and their impor-
tance in neurodegenerative research.
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miRNAs are signiﬁcantly upregulated in SIV/HIV CNS
disease. We ﬁrst examined the expression of miRNAs in
HIVE/SIVE human and monkey samples and control,
using miRNA microarrays on a locked nucleic acid
(LNA) technology-based platform. We compared miRNA
expression in between diseased and control tissue from two
regions of the brain known to be affected in HIV-induced
CNS disease, the striatum (using the caudate nucleus) and
the hippocampus. Both regions were examined in rhesus
monkeys with CNS disease (SIV encephalitis), in humans
with HIV encephalitis and HIV dementia only one region,
the caudate, was available for analysis. In all three sets
of samples, four miRNAs were signiﬁcantly upregulated,
based on a criterion of twofold change and P-value o0.05
(Table 1). None of the known neuron-enriched miRNAs were
signiﬁcantly altered. We then validated the expression
change of these four miRNAs by real-time PCR on both
regions of the monkey brains and in the human brain, and
conﬁrmed signiﬁcant upregulation of three: miR-21, miR-142-
3p and miR-142-5p (Figure 1). miR-142 expression is largely
conﬁned to the hematopoietic system, whereas miR-21
expression has been found in a number of cell types and
its altered expression linked to pathological changes. miR-21
was therefore chosen for further analysis.
miR-21 is induced in neurons of diseased brains. To
examine the cell type in the brain responsible for the
observed changes in miR-21 expression, in situ hybri-
dization was performed on sections from uninfected and
SIVE monkeys. miR-21 reactivity was minimal in uninfected
monkeys (Figure 2a), and hybridization of a control
scrambled miRNA probe to SIVE brains was negative
(Figure 2b). In contrast, intense reactivity for miR-21 was
found in brain tissue from animals with SIVE, including cells
morphologically identiﬁable as neurons (Figure 2c, hip-
pocampus, and 2D, entorhinal cortex). In situ hybridization
was then combined with immunostaining for the neuron-
speciﬁc protein MAP2, conﬁrming that the upregulation of
miR-21 is in neurons (Figure 3).
miR-21 is upregulated by neuronal stimulation through
NMDA receptors. Neuronal expression has not been
reported for miR-21. In HAND, as well as other neuro-
degenerative conditions, including AD, PD and HD,
overstimulation of NMDA-type glutamate receptors is a
likely mechanisms of neuronal injury.
9 Stimulation of NMDA
receptors leads to neuronal changes through cellular
signaling mechanisms including alterations in gene
expression.
10,11 To examine whether miR-21 expression is
part of the response in this pathway, we ﬁrst performed a
dose-response curve using a range of NMDA exposure for a
prolonged time (1h) and assessed miR-21 levels 24h after
the initial exposure in primary neurons from three different
human donors. Indeed, stimulation through NMDA receptors
led to a signiﬁcant increase in miR-21, with a peak response
at 100mM (Figure 4a). Under these conditions, there was no
increase in cell death in the cultures (determined by lactate
dehydrogenase release, data not shown). Repeating the
experiment at 100mM NMDA in four additional independent
donors conﬁrmed the miR-21 upregulation (Figure 4b).
The increased expression was not immediate, as miR-21
expression during the initial exposure to NMDA did not
change (Figure 4c). Furthermore, depolarization of the
neurons with KCl during this same time period did not
induce miR-21 (Figure 4d).
Table 1 Microarray analysis of miRNA expression in control and SIVE/HIVE brains
Log2 median ratios
Control Infected Infected versus control
Probe ID Annotation Mean S.D. Mean S.D. DLMR Fold t-test
Monkey caudate
5740 hsa-miR-21  1.09 0.25 0.09 0.62 1.17 2.26 0.0126
10947 hsa-miR-142-3p  0.84 0.41 0.35 0.82 1.18 2.27 0.0411
10964 hsa-miR-155  0.58 0.23 0.65 0.46 1.22 2.34 0.0031
10986 hsa-miR-193a-3p  0.80 0.40 0.28 0.27 1.08 2.11 0.0101
19015 hsa-miR-142-5p  0.84 0.28 0.51 0.40 1.35 2.55 0.0015
42550 hsa-miR-516a-5p  0.73 0.45 0.27 0.13 1.01 2.01 0.0053
Monkey hippocampus
5740 hsa-miR-21  0.52 0.32 0.80 0.43 1.32 2.50 0.0026
10947 hsa-miR-142-3p  1.01 0.50 1.11 0.24 2.12 4.34 0.0003
10986 hsa-miR-193a-3p  0.79 0.45 0.63 0.38 1.43 2.69 0.0029
19015 hsa-miR-142-5p  0.54 0.36 1.16 0.27 1.70 3.24 0.0003
Human caudate
5740 hsa-miR-21  1.414 0.20 0.32 0.68 1.74 3.33 0.0014
10947 hsa-miR-142-3p  1.152 0.20 0.25 0.89 1.40 2.63 0.0123
10986 hsa-miR-193a-3p  0.613 0.47 0.46 0.34 1.08 2.11 0.0138
19015 hsa-miR-142-5p  0.858 0.23 0.73 0.92 1.59 3.01 0.0083
RNA from two regions of the monkey and one region of the human brain, as indicated, was analyzed. Shown are the mean and standard deviation (S.D.) of the log2
median ratios for the probes corresponding to individual miRNAs. The difference in the means of the log2 median rations (DLMR) was calculated and the fold change
determined as 2
DLMR. Initial candidate miRNAs shown were chosen because of greater than twofold change and a t-test result of Po0.05
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Cell Death and DiseaseFigure2 Photomicrographsofmonkeybraintissue.InsituhybridizationformiR-21oncontroluninfectedbrainsisnegative(a).InbrainswithSIVEinsituhybridizationwith
a scrambled probe (b) is negative, whereas miR-21 (c) is positive in neurons in the hippocampus of SIVE brains. In cortical tissue foci of neurons are positive for miR-21 (d).
The brains of four control and four SIVE animals were examined. The chromagen revealing the positive reaction is blue, and nuclear fast red was used to counterstain cells.
Original magniﬁcation 200  (bar¼20mm) except (d) at 630  (bar¼10mm)
Figure 1 AlteredmiRNAexpressioninSIV/HIVinfectedbrains.(a)Monkeycaudate,(b)monkeyhippocampus,(c)humancaudate.Quantitativereal-timePCRconﬁrmed
the upregulation of miR-21, miR-142-3p and miR-142-5p, whereas the change in miR-193-3p did not reach statistical signiﬁcance. Mean and standard error of the mean
shown, *Po0.05, ***Po0.001
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Cell Death and DiseasemiR-21 overexpression affects neuronal physiology.
Although several functions of miR-21 has been reported, the
majority stress its role in various types of cancer and
tumors,
12 and its functional signiﬁcance in neurons has not
been investigated. In order to assess the effects of miR-21
on neuronal function, we transduced primary human neurons
with a lentivirus expressing miR-21 or a control lentivirus
(Figure 5a and b). We then performed electrophysiological
analysis of voltage-gated K
þ (Kv) channels, key regulators
of neuronal excitability. Under whole-cell voltage clamp
conﬁguration, application of depolarizing voltage steps
produced larger outward K
þ currents in neurons
transfected with a lentivirus expressing miR-21 than the
outward K
þ currents recorded in neurons transfected with a
control lentivirus (Figure 5c). When measured at þ60mV,
the average instantaneous outward K
þ current density
was 311.7±10.9pA/pF in miR21-transfected neurons
(mean±S.E.M., n¼75). In contrast, the average
instantaneous outward K
þ current density recorded in
neurons transfected with viral vector alone was
263.6±11.7 pA/pF (n¼67). The difference was statistically
signiﬁcant (Po0.001), revealing that miR-21 expression in
neurons produced an enhancement of the outward K
þ
current. These data reveal that miR-21 expression is indeed
detrimental to neurons, and thus, miR-21 induction in
neurons is a potential pathogenic factor in neurode-
generative disorders such as HAD and HAND.
MEF2C is a miR-21 target. With the help of target search
engines, we identiﬁed MEF2C as a putative target for miR-21.
MEF2C has been shown to be crucial in multiple aspects of
neuronal development, function and survival,
13–15 and in
adult mice MEF2C is critical in learning and memory.
16 We
therefore hypothesized that HIV-induced neurocognitive
deﬁcits could be due to repression of the MEF2C mRNA by
miR-21.
To examine whether miR-21 could regulate expression via
the 30-UTR of the MEF2C mRNA and thereby regulating its
expression, we co-transfected a luciferase reporter vector
containing the MEF2C 30-UTR along with a vector expressing
eithermiR-21,a miRNA without a targetinthe MEF2C 30-UTR
(miR-181), or a scrambled miRNA sequence in HEK293T
cells. Initial experiments revealed that MEF2C 30-UTR
expression is repressed by miR-21, but not by a scrambled
control miRNA or an irrelevant miRNA (data not shown). To
assess whether this regulation is indeed because of miR-21
recognizing its predicted binding site in MEF2C rather than
other nonspeciﬁc actions, we mutated the miR-21 site in
Figure 3 Combined in situ and immunostaining of monkey brain tissue. In situ hybridization for scrambled probe (a) and miR-21 (b) on control uninfected brains is
negative.In brainswith SIVEin situhybridizationwith a scrambledprobe(c)is negative,whereasmiR-21 (d) ispositive(pink). Anti-MAP2staining(green) labelstheneurons.
Original magniﬁcation 200 
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Cell Death and DiseaseMEF2C. Nucleotides 2–8 of the guide strand (known as the
‘seed’ region) are crucial determinants of the speciﬁcity of
target recognition by miRNAs. As seen in Figure 6a, there is a
perfect match in the seed sequence between miR-21 and
complementary nucleosides in the 30-UTR of the MEF2C
mRNA. We then mutated the seed region in MEF2C for miR-
21binding(Figure6a) andperformedthe luciferaseassaysas
above. While the wild-type MEF2C shows signiﬁcant repres-
sion by miR-21, the mutant MEF2C does not (Figure 6b). As
an additional control, we also tested a random genomic
sequence within the luciferase vector, which showed no
change upon co-transfection with miR-21.
We next transduced HEK293T cells with miR-21 and a
scrambled control, and examined their effect on the endo-
genous MEF2C expression. Compared with the control-
transduced cells, miR-21 expression decreased MEF2C
expression in cells (Figure 6c). After conﬁrming our results
in HEK293T cells, we transduced human embryonic neurons.
A similar effect was seen in neurons, miR-21 overexpressing
neurons showed a reduction in MEF2C protein levels as
compared with scrambled control (Figure 6d). Our results
clearly demonstrate that MEF2C is repressed by miR-21,
dependent on the seed region, and therefore is a deﬁnite
target for miR-21.
MEF2C is repressed in neurons of diseased brains.
MEF2C is expressed in neurons in regions that are
functionally affected in HAND, including the frontal cortex
and hippocampus.
17,18 In order to examine whether MEF2C
is altered in neurons in diseased brains we performed
immunohistochemical staining on brain sections control and
diseased monkey (SIVE) and human (with clinical HAD, and
neuropathological HIVE) brains. While neurons from control
brains show robust MEF2C immunoreactivity in neuronal
nuclei (Figures 7a,b, e and f), neurons in the hippocampus
and cortex from diseased monkeys and humans have
a profound decrease in MEF2C protein expression
(Figure7c,d, g and h).
Discussion
Inthis study,we reportfortheﬁrst timethe abnormalinduction
of miRNA in neurons in a neurocognitive disorder, HAD/HIVE,
and its animal model, SIVE. Our microarray and follow-up
validation with qPCR in monkeys and humans clearly shows
signiﬁcant induction of miR-21. Using in situ hybridization on
brain sections we have demonstrated the increase of this
miRNA in neurons.
Figure 4 Regulation of miR-21 expression in human neurons. The Y axes indicate the fold change, determined as 2
–DDCt by normalizing to baseline as 1. (a) miR-21
expressioncurveforincreasingconcentrationsofNMDA(measured24haftera15minexposure).Dataarefromthreeindependentdonors/experiments.Repeatedmeasures
one-way ANOVA analysis of the DCt values revealed a signiﬁcant difference (Po0.001), Tukey’s post hoc test revealed signiﬁcance between untreated cells and those
treated with NMDA at 25mM( Po0.05), 100mM( Po0.001) and 250mM( Po0.01), and for those treated with 100mM NMDA compared with those at 25mM( Po0.05),
250mM(Po0.05)and1000mM(Po0.01).(b)miR-21expressioninfouradditionaldonorsatthepeak(100mM)NMDAconcentration.Pairedt-testanalysisoftheDCtvalues
revealed a signiﬁcant difference (Po0.001). (c) miR-21 expression as a result of short-term NMDA stimulations. No signiﬁcant difference was seen. Data are from three
independentdonors/experiments.(d)miR-21expressionasaresultofshort-termKClstimulation.Nosigniﬁcantdifferencewasseen.Dataarefromthreeindependentdonors/
experiments
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Cell Death and DiseasemiR-21 has been shown to be a marker for many types of
cancer including brain gliomas.
19 However, neuronal expre-
ssion has not been previously identiﬁed. We ﬁnd that
stimulation of NMDA receptors leads to increased expression
of miR-21 in neurons.There is precedent forincreased NMDA
receptorsignalingtobeakeycomponentofHIV-inducedCNS
disease, as viral proteins such as gp120 and Tat
20,21 and
low molecular weight non-proteinaceous products of macro-
phages,
22,23 the key pathogenic cells in the brain, lead to
neuronal damage and death through these receptors. Given
the prime role of NMDA receptors in mechanistic pathways of
neurodegenerative disorders, the induction of miR-21 can
represent a key event in subsequent neuronal injury.
In order to delineate the functional relevance of miR-21
upregulation in neurons, we examined speciﬁc gene targets
for miR-21. While a number of targets for miR-21 have been
uncovered in studies on cancer and other cell types,
we focused our search on targets to neuronal genes. To our
interest, we found MEF2C, a CNS transcription factor as a
targetgeneformiR-21.WhilemiR-21isrelativelywellstudied,
this target has not been reported so far for miR-21. One
possible reason for this is many investigators use mouse
models and miRNA target prediction algorithms that rely on
evolutionary conservation. While the miR-21 sequence is well
conserved in mammals and other vertebrates,
19 an examina-
tion of sequenced genomes reveals that the seed sequence
Figure 5 miR-21 alters functional properties of human neurons. (a) Representative image of human fetal brain derived neurons, stained with anti-MAP2 and DAPI.
(b) Representative image of lentiviral transduced neurons, revealing the positive GFP marker in the miR-21 containing FUGW vector. (a and b—original magniﬁcation 100 ,
bar¼50mm). (c) Transduction of human fetal neurons with miR-21 induced an increase of whole-cell outward K
þ currents generated by voltage steps shown at the top left. The
representative current traces were recorded froma neuron withthe control viral vector (left) and another neuron with the miR-21 viral vector (middle). Note much larger outward K
þ
currents were recorded fromthemiR-21-tranduced neuron thanthose recorded from the neuron transducedwith vector alone. The current-voltage (I–V) relationship(right) showing
the average of current densities recorded in neurons transduced with miR-21 (n¼75) and controls (n¼67), respectively, obtained from three different donors. Mean and standard
error of the mean shown, signiﬁcance is indicated by *Po0.05, **Po0.01, ***Po0.001. Statistics were performed on data from three independent donors
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Cell Death and Diseaseidentiﬁed within the MEF2C mRNA is present within primates
(human, chimpanzee, rhesus monkey) and many other
mammals (including horse, cow, dog, rabbit, elephant,
platypus), but not in mouse or rat (or opossum). In our study,
aswithmanyothersonmiRNAsandtheirtargets,thistargetis
linked to functional defects, however, we note that as each
miRNA has multiple targets, the disease phenotype can be
due to the combined effect of the dysregulated miRNA on
numerous genes.
Our results clearly demonstrate that MEF2C is repressed
by miR-21, dependent on the seed region, and therefore,
is a deﬁnite target for miR-21. MEF2C has been of much
interest to neuroscientists. It has been shown to be crucial for
neuronal survival and its complete deﬁciency experimentally
leads to an autism-like phenotype in mice.
13,14 Other studies
have found that in adult mice MEF2C is critical in learning and
memory.
16 While no deﬁcits have been reported in mice
carrying only one functional copy of MEF2C, in humans
a number of investigators have recently reported that
haploinsufﬁciency of MEF2C leads to severe mental retarda-
tion.
24 Thus, similar to the targeting of MEF2C by miR-21,
the functions of MEF2C are not fully captured in rodent
models.
In order to look for functionality of miR-21 expression in
neurons, we performed electrophysiological studies on
neurons transfected with lentiviruses expressing miR-21.
The results clearly showed that expression of miR-21 resulted
in a signiﬁcant enhancement of outward K
þ current. Such an
increase is an early step in neuronal apoptosis, before
commitment to cell death,
25 although we did not observe
neuronal death due to miR-21 expression at the time point
when electrophysiological studies were performed. While the
biological signiﬁcance of miR-21-induced enhancement of
neuronal outward K
þ current remains to be determined, we
postulate it might reﬂect a part of pathogenesis of neurode-
generative disorders such as HAD. Genetic targeting studies
reveal that Kv channels have a great importance in the
memory processes.
26,27 Intriguingly, it has been also shown
that MEF2 proteins target Kv1.1.
28 We do not know as of now
whether MEF2C in particular would directly target potassium
channel genes, but it is a fascinating aspect to consider.
Interestingly, loss of MEF2C in mice leads to increased
neuronal excitatory input.
16 One possibility is that an
autostimulatory cycle is created, increased excitatory input
through NMDA receptors leads to increased miR-21 and
decreased MEF2C, resulting in further increased excitatory
Figure 6 MEF2C is a target of miR-21. (a) Alignment and base pairing of miR-21 with the MEF2C 30-UTR. The seed region (bases 2–8) is indicated in capital letters.
In vitro mutagenesis of the wild-type (wt) MEF2C sequence (upper) to alter the seed sequence and create the mutant (mut) sequence in the seed region is shown in italics
(lower). (b) MiR-21 signiﬁcantly lowers the activity of the wild-type MEF2C luciferase reporter, but not the mutant MEF2C or a random DNA sequence. This experiment was
repeatedinthreeindependentexperiments.(c)HEK293Tcellsor(d)humanembryonicneuronsweretransducedwitheithercontrolFUGWormiR-21-FUGWlentiviralvector.
Cells were immunostained for MEF2C, as seen in the second panel, the reactivity for MEF2C decreases in miR-21 transduced cells (630  magniﬁcation, bar¼10mm).
Mean and standard error of the mean shown, signiﬁcance is indicated by **Po0.01
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Cell Death and DiseaseFigure 7 Photomicrographs of monkey and human brain tissue. Immunohistochemical staining for MEF2C reveals positive staining in hippocampal (a) and cortical (b)
neuronsofcontroluninfectedmonkeys.InmonkeyswithSIVEmuchlessreactivityisseeninhippocampal(c)andcorticalneurons(d).Tissuefromfourmonkeysineachgroup
was examined. The same result is seen in the cortex of humans, with stronger reactivity is seen in neurons in the frontal cortex of brains from individuals without HIV
neurological symptoms (e and f, representing two of the four cases examined) when compared with those with HIV-associated dementia (g and h, representing two of
the three cases examined). The chromagen revealing the positive reaction is brown, and methyl green (light green) used for counterstaining. Original magniﬁcation
200  (bar¼20mm) except inserts at 630  (bar¼10mm)
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Cell Death and Diseaseinput, which maintains or further increases miR-21 and
decreases MEF2C (Figure 8). Such a cycle would result in
neuronal dysfunction and possibly excitotoxic death.
miRNA expression in frontal cortical gray matter miRNAs
was examined in another study looking at the effect of
depression in HIV infected individuals, but miR-21 was not
identiﬁed as having this association.
29 In addition, similar to
our studies with NMDA treatment of human neurons, the HIV
protein Tat was used to treat rodent neurons, revealing the
upregulation of miR-128a but not miR-21.
30 However, there
are signiﬁcant interspecies differences between rodent and
human neurons in response to Tat,
31 and such studies would
need to be repeated with human neurons. Thus, it is possible
that in addition to NMDA, viral proteins as well as other
molecules implicated in the neuropathogenesis of HIV could
result in alterations of miR-21 in human neurons (Figure 8).
Interestingly, another recently reported study examined
miRNAs in subcortical white matter in HIVE, and found a
number of up- and down-regulated molecules.
32 In that study,
downregulationofmiRNAswaslinkedtoincreasedcaspase-6
in astrocytes and astrocyte injury. miR-21 was not identiﬁed,
likely because of the examination of white matter versus the
neuron-rich regions studied here. Inﬁltration and activation of
macrophages in the brain is a well-characterized neuropatho-
logical component of SIVE/HIVE. While miRNAs have also
been studied in macrophages in relationship to HIV infection
and interferon production,
33,34 changes in miR-21 or others
miRNAs in macrophages in CNS disease have not yet been
reported.
Our data provides compelling evidence that MEF2C is an
important target for miR-21 in neurons. miR-21 induction,
through repression of MEF2C and potentially other genes,
could lead to deﬁcits in neurocognitive functions as seen in
HIV infection and possibly other disorders. These studies also
reveal additional reasons why rodent systems may not be
optimal for the study of certain neurodegenerative condi-
tions.
35Ourstudy inhumans andnonhumanprimates thereby
provides a unique mechanism of disease: neuronal induction
of miRNAs in a setting of CNS infection, revealing a novel
mechanism of dysregulation of CNS function and providing
new avenues in brain research.
Materials and Methods
Ethics statement. The monkey samples were from rhesus macaques used in
our previous studies on SIV pathogenesis
36,37 that were performed under IACUC
approval from The Scripps Research Institute. Human RNA samples were obtained
from the National NeuroAIDS Tissue Consortium (NNTC) (http://www.nntc.org),
operating under IRB approval from the participating institutions (University of
California San Diego, University of California Los Angeles, University of Texas
Medical Branch at Galveston, and Mt. Sinai Medical Center in New York). Fetal
brain tissue for primary neuronal culture was obtained in full compliance with the
ethical guidelines of the NIH and under IRB approval from the University of
Washington and the University of Nebraska Medical Center.
Figure 8 Model of autostimulatory neuropathogenic cycle. In CNS HIV infection, NMDA receptors (NMDA-R) can be activated through their normal ligand glutamate, as
well as HIV proteins and/or excitatory molecules from macrophages. This increased excitatory input results in induction of miR-21 that decreases MEF2C, resulting in further
increased excitatory input. This neuronal damage, along with alterations in the other neuronal functions involving MEF2C, results in cognitive dysfunction
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Cell Death and DiseasemiRNA microarray studies. Total cellular RNA was isolated from frozen
( 801C) brain specimens by using TRIzol (Invitrogen, Carlsbad, CA, USA) for
themonkeysamples,andRNAzol(BiotecxLaboratories,Houston,TX,USA) for the
human samples,followed by column puriﬁcation (miRNeasy, Qiagen, Valencia, CA,
USA) as per manufacture’s instructions. For the monkeys, four samples were from
uninfected animals and four from SIV-infected animals that developed simian AIDS
with SIV encephalitis. For the human samples, six samples were from individuals
who were HIV negative with no history of dementia or neurocognitive disability and
showed no signiﬁcant neuropathology. Five samples were from HIV positive
individuals that were neurocognitively impaired (NNTC clinical rating 46)
38 and a
neuropathological diagnosis of HIV encephalitis. Clinical information is provided
in the supplemental material. For microarray analysis, only three of the HAD
specimens were sufﬁcient for use, but all ﬁve were used for the qRT-PCR studies.
miRNA microarray analysis was performed by using the miRCURY LNA
microarray (version 11.0) microRNA at Exiqon S/A (Vedbaek, Denmark). The
microarray data have been deposited in NCBI’s gene expression omnibus and are
accessible through GEO (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?).
miRNA quantitative real-time PCR (qRT-PCR). For the brain RNA
samples, qRT-PCR was performed on the same samples used for microarray
analysisaboveatExiqon.Endogenouscontrolswerechosenbasedontheirrelative
stability on the microarrays, and the three best endogenous controls (let-7e, let-7C,
andmiR-423-3p)wereusedfornormalizingthequantiﬁedsignalofthemiRNAs.For
the primary human neuronal culture RNA samples, Taqman qRT-PCR assays for
hsa-miR-21 and U6 snRNA for endogenous control were purchased and performed
as per manufacturer’s instructions from (ABI, Carlsbad, CA, USA).
The relative expressions were calculated based on the efﬁciency corrected Ct
method; the PCR efﬁciency was estimated from a serial dilution of cDNA generated
from pooled RNA of the samples. Data (in log2 format) were exported into Excel
(Microsoft, Redmond, WA, USA) and analyzed for differential expression by using
the two-tailed Student’s t-test (for two-group comparisons) or into Prism (GraphPad
Software, San Diego, CA, USA) for one-way ANOVA followed by post hoc testing
(for multiple group comparisons).
miRNA in situ hybridization. Following necropsy, monkey caudate and
hippocampus were formalin ﬁxed, and embedded in parafﬁn, and 5mm sections cut
onto glass slides. The in situ hybridization was performed at Phylogeny Inc.
(Columbus, OH, USA) as described previously.
39 Monkey spleen was used as a
positive control. At least two hybridizations were done for each probe on each brain
section.
Combined in situ hybridization and immunoﬂuorescence. We
adapted our protocol for radiolabelled in situ hybridization and colorimetric
immunohistochemisty
7 to ﬂuorescence as follows. Following deparafﬁnization
andantigenretrievalwithcitrate,sectionswerepre-hybridizedinhybridizationbuffer
(50% formamide, 10mM Tris-HCl, pH 8.0, 200mg/ml yeast tRNA, 1  Denhardt’s
solution, 600mM NaCl, 0.25% SDS, 1mM EDTA, 10% dextran sulfate) for 1h at
371C in a humidiﬁed chamber. LNA modiﬁed miR-21 and scrambled miR probes,
labeled at both the 50 and 30 ends with digoxigenin (Exiqon), were diluted to ﬁnal
concentration of 2 pM in hybridization buffer, heated to 651C for 5min, and
separately hybridized to the sections at 371C overnight. The slides were then
washed twice in hybridization buffer (without probe) at 371C, followed by washing
three times in 2  SSC and twice in 0.2  SSC at 421C. They were then blocked
with 1% BSA, 3% normal goat serum in 1  PBS for 1h at room temperature and
incubated with anti-digoxigenin conjugated with horseradish peroxidase (1:100,
Roche Diagnostics GmbH, Mannheim, Germany) and anti-MAP2 (1:1500,
Sternberger Monoclonals Inc., Baltimore, MD, USA) antibodies overnight at 41C.
The slides were washed twice with PBS and incubated with Alexa Fluor 568 goat
anti-mouse IgG (1:400, Invitrogen) antibody for 1h at room temperature. This was
followed by two PBS washes and signal ampliﬁcation (for the in situ, now labeled
with horseradish peroxidae) using TSA Cy5 kit (PerkinElmer, Waltham, MA, USA)
according to the manufacturer’s protocol. The slides were mounted in Prolong gold
anti-fade reagent with DAPI (Invitrogen).
Isolation, cultivation and treatments of human neurons. Fetal
brain tissue (ﬁrst/second trimester) was obtained from the Birth Defects Laboratory,
University of Washington, Seattle, WA, USA. Neuronal cultures were prepared by
incubating dissociated tissue with 0.25% trypsin for 30min, neutralized with 10%
fetal bovine serum, and further dissociating by triturating. The resulting single
cell suspension was cultured on poly-D-lysine-coated plates in neurobasal media
containing 0.5mM l-glutamine, 50mg/ml penicillin and streptomycin and
supplemented with B27 (Invitrogen). Matured neurons were stained with a
neuronal-speciﬁcMAP2antibody(Calbiochem,SanDiego,CA,USA)to conﬁrmthe
purity.
For NMDA and KCL treatments, neurons were grown to 15 days in vitro (DIV)
and cultures were then treated with the indicated concentrations of NMDA and
10mM glycine. After 1h treatment, cultures were replaced with normal neuronal
medium.After24h,theneuronswerecollectedinTRIzolandRNAwasextractedfor
analysis. For KCL stimulation, treatment was carried out for 15min at the indicated
concentrations before the extraction of RNA.
For lentivirus transduction, neurons were transduced with miR-21 or control
lentivirus at a biological titer of 1 10
10 transduction units/ml at 7 DIV. Neurons
were cultured for another 4 days after transduction, used for MEF2C
immunoﬂuorescence or electrophysiology, which was performed on GFP positive
cells.
miR-21 expressing lentivirus. We generated a miR-21 lentiviral vector by
subcloning the precursor miR-21 fragment into the Pac1/Nhe1 cloning sites of the
FUGW, a self inactivating, replication incompetent lentiviral vector that carries the
humanubiquitin-Cpromoterdriving a GFPreporter gene. Human embryonickidney
293T cells were transfected by using Fugene 6 (Roche Applied Science,
Indianapolis, IN, USA) with the expression vector and two helper plasmids, D8.9
and vesicular stomatitis virus G protein. Virions were isolated by ultracentrifugation
ofﬁlteredsupernatant.Forthecontrolvirus,thevectorwithoutthemiR-21insertwas
used.
Electrophysiology. Whole-cell voltage-clamp recordings were performed on
transduced (GFP-positive) primary human neuronal cultures (from three donors) in
35mm tissue culture dishes on the stage of an inverted Nikon microscope (TE 300)
using an Axonpatch 200B ampliﬁer (Molecular Devices, Sunnyvale, CA, USA).
Patch electrodes, made from borosilicate glass micropipettes (WPI Inc., Sarasota,
FL, USA) with a P-97 micropipette puller (Sutter Instruments, Novato, CA, USA),
had tip resistance of 5.0–8.0MO. The electrodes were advanced toward cells by a
Burleigh micromanipulator (PC-5000, EXFO, Mississauga, ON, Canada). After
establishment of the whole-cell patch conﬁguration, the cells were allowed to
stabilize for 3–5min before tests. The recorded cells were held at  60mV during
voltage clamping. Whole-cell outward K
þ currents were induced by applying
depolarizing voltage steps (300ms in duration) from the holding potential of
 60mV to  40mV in the ﬁrst step, and then stepped to þ60mV in increments of
10mV. Junction potentials were corrected, and the cell capacitance was
uncompensated. Current signals were ﬁltered at 1kHz and digitized at 5kHz
using Digidata 1440A digitizer (Molecular Devices). The current and voltage traces
were displayed and recorded in a Dell computer using pCLAMP 10.2 data
acquisition/analysis system (Molecular Devices).
The pipette and extracellular solutions for voltage-clamp experiments were as
described by Sodickson et al.
40 In order to block voltage-gated sodium channels,
1.0mM tetrodotoxin (Tocris Bioscience, Ellisville, MO, USA) was added to the
extracellular solution. All experiments were done at room temperature (22–231C).
Data was analyzed using Clampﬁt 10.2 software (Molecular Devices). For I–V
curves,the current densities of the instantaneous outwardKþ currents, generated
by voltagesteps, were measuredand analyzedin each group. Student’st-test (two-
tailed) was employed for statistical analyses.
30-UTR analysis for miRNA regulation. The MEF2C 30-UTR luciferase
reporter vector was purchased from Switchgear Genomics (Menlo Park, CA, USA),
and the precursor miRNA containing vectors from Cellbiolabs (San Diego, CA,
USA). Site-directed mutagenesis was performed using the QuickChange Lightning
kit (Stratagene, La Jolla, CA, USA). To test suppression by miRNA, the miRNA of
interest was co-transfected into HEK293T cells with the indicated 30-UTR luciferase
reporter and with Renilla luciferase (pRL-TK Vector, Promega, Madison, WI, USA)
as a transfection efﬁciency control. The luciferase signal was measured with Duo-
Gloluciferaseassaykit(Promega).Thenormalizeddata(thesignalfromthe30-UTR
ﬁreﬂy luciferase to the control Renilla luciferase) were imported into Prism
(GraphPadSoftware)andanalyzedbyone-wayANOVA.WhentheANOVAP-value
waso0.05theNewman–Kuelsmultiplecomparisontestwasusedtoassessgroup
differences.
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(Human Protein Atlas antibody ID# HPA005533 from the Human Proteome
Resource program, distributed by Sigma, St. Louis, MO, USA) was used for
all studies. Immunoﬂuorescence was performed on cells transduced with GFP-
expressing lentiviral control and miR-21 constructs. An Alexaﬂour 488 goat-anti
rabbit secondary antibody (Invitrogen) was used for detection followed by mounting
with Prolong gold antifade reagent containing DAPI (Invitrogen).
Immunohistochemistry was performed on 5–6mm formalin-ﬁxed, parafﬁn-
embedded tissue blocks from the monkey hippocampus and human frontal cortex.
Antigen retrieval was performed by heating in citrate buffer. For detection,
SuperPicture broad spectrum secondary antibody-horseradish peroxidase polymer
reagent (Invitrogen) was used followed by chromogenic development with 3,30-
diaminobenzidine and a methyl-green counterstain.
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